Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 75 entries
View as:

Study to Assess the Effect of Treatment With Bendamustine in Combination With Rituximab on QT Interval in Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL)

Phase: N/A Priority: Normal
NCT ID: NCT01073163 Org: User:
Start: 02/28/10 End: 06/30/12 Due: 06/30/13

Safety and Efficacy of SDX-101 (R-Etodolac) in Patients With Relapsed or Refractory Multiple Myeloma (MM)

Phase: N/A Priority: Normal
NCT ID: NCT00293111 Org: User:
Start: 02/28/02 End: - Due: -

Safety and Efficacy of SDX-101 (R-Etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, in Patients With Chronic Lymphocytic Leukemia (CLL)

Phase: N/A Priority: Normal
NCT ID: NCT00151736 Org: User:
Start: 09/30/04 End: 02/29/08 Due: 02/28/09

Study to Evaluate Armodafinil Treatment in Improving Prefrontal Cortical Activation and Working Memory Performance

Phase: N/A Priority: Normal
NCT ID: NCT00711516 Org: User:
Start: 09/30/08 End: 10/31/09 Due: 10/31/10

Study of CEP-9722 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors or Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01345357 Org: User:
Start: 05/31/11 End: 01/31/13 Due: 01/31/14

Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Previously Untreated Patients With Indolent B-Cell Non-Hodgkin's Lymphoma (NHL)

Phase: N/A Priority: Normal
NCT ID: NCT01108341 Org: User:
Start: 05/31/10 End: 10/31/11 Due: 10/31/12

A 10-Week Efficacy and Safety Study for of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00236054 Org: User:
Start: 10/31/04 End: 12/31/05 Due: 12/31/06

Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00078312 Org: User:
Start: 01/31/04 End: 07/31/06 Due: 07/31/07

Open Study of CEP-701 in Patients With Refractory Acute Myeloid Leukemia With FLT-3 Mutation

Phase: N/A Priority: Normal
NCT ID: NCT00030186 Org: User:
Start: 01/31/02 End: 02/28/03 Due: 02/28/04

Study to Evaluate the Safety and Efficacy of Placulumab (CEP-37247) Administered by the Transforaminal Epidural Route for the Treatment of Patients With Lumbosacral Radicular Pain Associated With Disk Herniation

Phase: N/A Priority: Normal
NCT ID: NCT01240876 Org: User:
Start: 01/31/11 End: 04/30/13 Due: 04/30/14

Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness

Phase: N/A Priority: Normal
NCT ID: NCT00228553 Org: User:
Start: 05/31/04 End: 07/31/06 Due: 07/31/07

Safety and Activity of SDX-105 (Bendamustine) in Patients With Rituximab Refractory Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00069758 Org: User:
Start: 09/30/03 End: 04/30/07 Due: 04/30/08

A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00236067 Org: User:
Start: 10/31/04 End: 03/31/06 Due: 03/31/07

Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms When Used for the Management of Breakthrough Pain

Phase: N/A Priority: Normal
NCT ID: NCT00387010 Org: User:
Start: 12/31/06 End: 10/31/07 Due: 10/31/08

Bendamustine Hydrochloride in Combination With Rituximab in Patients With Relapsed Refractory Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00891839 Org: User:
Start: 06/30/09 End: 05/31/14 Due: 05/31/15

Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00228566 Org: User:
Start: 10/31/05 End: 07/31/06 Due: 07/31/07

Single Ascending-Dose Study to Characterize the Safety, Pharmacokinetics, and Pharmacodynamics of CEP-37251 in Healthy Postmenopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT01159873 Org: User:
Start: 07/31/10 End: 10/31/10 Due: 10/31/11

PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00107848 Org: User:
Start: 10/31/04 End: 09/30/05 Due: 09/30/06

Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00107809 Org: User:
Start: 10/31/04 End: 09/30/05 Due: 09/30/06

Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHD

Phase: N/A Priority: Normal
NCT ID: NCT00214981 Org: User:
Start: 09/30/03 End: 09/30/06 Due: 09/30/07

Efficacy and Safety of Armodafinil as Adjunctive Therapy in Schizophrenic Adults With Cognitive Deficits

Phase: N/A Priority: Normal
NCT ID: NCT00487942 Org: User:
Start: 07/31/07 End: 12/31/07 Due: 12/31/08

A Study to Assess the Abuse Potential of Hydrocodone Extended-Release Tablet in Recreational Opioid Users

Phase: N/A Priority: Normal
NCT ID: NCT01596673 Org: User:
Start: 03/31/12 End: 05/31/12 Due: 05/31/13

Efficacy and Tolerability of Armodafinil in Adults With Excessive Sleepiness Associated With Shift Work Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01080807 Org: User:
Start: 03/31/10 End: 10/31/10 Due: 10/31/11

Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)

Phase: N/A Priority: Normal
NCT ID: NCT00236041 Org: User:
Start: 04/30/04 End: 08/31/06 Due: 08/31/07

Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome(OSAHS)

Phase: N/A Priority: Normal
NCT ID: NCT00078325 Org: User:
Start: 02/29/04 End: 11/30/04 Due: 11/30/05